Investment
Features
FeesSafety
Academy
More
Pluang+

Royal Road Minerals expands high-grade silver-gold-antimony veins in Colombia, with system open at depth and north.

Market News
07 Oct 2026
Proactive Investors
View Source
Bullish
Royal Road Minerals expands high-grade silver-gold-antimony veins in Colombia, with system open at depth and north.

Royal Road Minerals has significantly expanded the known area of high-grade silver-gold-antimony veins at its Margaritas target in Colombia, now covering about 400 by 450 meters and remaining open to the north and at depth. Initial drilling intersected multiple high-grade veins, and recent rock-chip samples show strong silver, gold, and antimony values, suggesting a nearby undiscovered bedrock source. The company plans further drilling to test the expanded vein system and explore a potential porphyry target indicated by geological mapping. This expansion could increase the project's resource potential and attract further investment interest.

Royal Road Minerals' expansion of its Colombian silver-gold-antimony vein system is presented here with Pluang Basic Materials sector data as of Oct 07, 2026 20:22 WIB: out of 38 priced US stocks, 8 rose and 28 fell. Notable movers include AEM at USD 180.50 with a -2.97% change, KGC at USD 23.11 with a -2.94% change and full buy order activity, and NEM at USD 113.07 with a -2.85% change. The most notable figure is KGC's 100% buy order activity on Pluang.

More News

Rocket Pharmaceuticals' price target cut to $2.95 amid gene therapy progress and new funding.

Rocket Pharmaceuticals' price target cut to $2.95 amid gene therapy progress and new funding.

Jefferies analyst Andrew Tsai lowered Rocket Pharmaceuticals' price target to $2.95, with shares trading at $2.48. The company is advancing its gene therapy for Danon disease, RP-A501, with an FDA-aligned pivotal study plan. Rocket secured $35 millio...

Analyst Insights
Bearish
3 hours ago
Eight firms boost Zscaler price targets, signaling 29% upside despite mixed analyst views.

Eight firms boost Zscaler price targets, signaling 29% upside despite mixed analyst views.

Eight Wall Street firms raised their price targets for Zscaler following the company's $10 billion Annual Recurring Revenue (ARR) goal announcement, with targets now implying a 29% upside from current prices. While most analysts maintain Buy or Overw...

Analyst Insights
Bullish
4 hours ago
China boosts gold reserves by 21 tonnes in September, largest monthly increase in 3 years.

China boosts gold reserves by 21 tonnes in September, largest monthly increase in 3 years.

In September, China increased its gold reserves by 21 tonnes, marking the biggest monthly gain in three years and continuing a 23-month streak of purchases. This move came as gold prices fell, with the People's Bank of China now holding 2,196 tonnes ...

Market News
Bullish
4 hours ago
Halma gets Stifel ‘buy’ rating with 26.5% upside despite Avo Photonics risks

Halma gets Stifel ‘buy’ rating with 26.5% upside despite Avo Photonics risks

Stifel resumed coverage of Halma PLC with a 'buy' rating and a 4,500p price target, citing a 26.5% upside potential. The broker believes investors are overly cautious about risks from Avo Photonics, Halma's optical switch supplier for AI data centers...

Analyst Insights
Bullish
4 hours ago
Constellation Brands beats Q2 estimates with strong beer and wine sales, despite softer alcohol demand.

Constellation Brands beats Q2 estimates with strong beer and wine sales, despite softer alcohol demand.

Constellation Brands reported a 6% rise in net sales to $2.63 billion and a 3% increase in earnings per share to $3.74 for the quarter ending August 31. Strong beer sales, particularly from Pacifico, Victoria, and Modelo Chelada, helped offset weaker...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App